CareDx Revenue 2013-2024 | CDNA
CareDx revenue from 2013 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| CareDx Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $280 |
| 2022 | $322 |
| 2021 | $296 |
| 2020 | $192 |
| 2019 | $127 |
| 2018 | $77 |
| 2017 | $48 |
| 2016 | $41 |
| 2015 | $28 |
| 2014 | $27 |
| 2013 | $22 |
| 2012 | $20 |
| CareDx Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-03-31 | $72 |
| 2023-12-31 | $66 |
| 2023-09-30 | $67 |
| 2023-06-30 | $70 |
| 2023-03-31 | $77 |
| 2022-12-31 | $82 |
| 2022-09-30 | $79 |
| 2022-06-30 | $81 |
| 2022-03-31 | $79 |
| 2021-12-31 | $79 |
| 2021-09-30 | $76 |
| 2021-06-30 | $74 |
| 2021-03-31 | $67 |
| 2020-12-31 | $59 |
| 2020-09-30 | $53 |
| 2020-06-30 | $42 |
| 2020-03-31 | $38 |
| 2019-12-31 | $36 |
| 2019-09-30 | $34 |
| 2019-06-30 | $31 |
| 2019-03-31 | $26 |
| 2018-12-31 | $24 |
| 2018-09-30 | $21 |
| 2018-06-30 | $18 |
| 2018-03-31 | $14 |
| 2017-12-31 | $13 |
| 2017-09-30 | $12 |
| 2017-06-30 | $12 |
| 2017-03-31 | $12 |
| 2016-12-31 | $11 |
| 2016-09-30 | $12 |
| 2016-06-30 | $11 |
| 2016-03-31 | $7 |
| 2015-12-31 | $7 |
| 2015-09-30 | $7 |
| 2015-06-30 | $7 |
| 2015-03-31 | $7 |
| 2014-12-31 | $8 |
| 2014-09-30 | $7 |
| 2014-06-30 | $7 |
| 2014-03-31 | $6 |
| 2013-12-31 | $6 |
| 2013-09-30 | $6 |
| 2013-06-30 | $5 |
| 2013-03-31 | $5 |
| 2012-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.732B | $0.280B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.209B | 15.59 |
| Cencora (COR) | United States | $47.206B | 18.40 |
| ICON (ICLR) | Ireland | $26.298B | 24.83 |
| DiDi Global (DIDIY) | China | $21.580B | 0.00 |
| Avantor (AVTR) | United States | $15.025B | 22.12 |
| CochLear (CHEOY) | Australia | $14.104B | 0.00 |
| Revvity (RVTY) | United States | $13.324B | 23.37 |
| Natera (NTRA) | United States | $13.153B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.518B | 41.19 |
| Viatris (VTRS) | United States | $12.466B | 3.73 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.906B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.900B | 20.87 |
| Solventum (SOLV) | United States | $9.041B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.666B | 0.00 |
| HealthEquity (HQY) | United States | $7.278B | 46.73 |
| Organon (OGN) | United States | $5.359B | 5.08 |
| Bausch + Lomb (BLCO) | Canada | $5.253B | 21.03 |
| Doximity (DOCS) | United States | $5.103B | 35.74 |
| PACS (PACS) | United States | $4.437B | 0.00 |
| Life Times (LTH) | United States | $3.659B | 38.33 |
| Sotera Health (SHC) | United States | $3.400B | 16.68 |
| Surgery Partners (SGRY) | United States | $3.113B | 28.48 |
| GoodRx Holdings (GDRX) | United States | $2.900B | 110.43 |
| Agilon Health (AGL) | United States | $2.681B | 0.00 |
| Progyny (PGNY) | United States | $2.462B | 42.39 |
| NovoCure (NVCR) | Jersey | $2.052B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.013B | 7.98 |
| Premier (PINC) | United States | $1.950B | 8.34 |
| BrightSpring Health Services (BTSG) | United States | $1.819B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.647B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.388B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.141B | 0.00 | |
| Embecta (EMBC) | United States | $0.721B | 4.91 |
| GeneDx Holdings (WGS) | United States | $0.717B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.673B | 7.14 |
| InnovAge Holding (INNV) | United States | $0.646B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.599B | 0.00 |
| Sharecare (SHCR) | United States | $0.497B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.437B | 11.45 |
| Enhabit (EHAB) | United States | $0.428B | 42.70 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.427B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.370B | 0.00 |
| ModivCare (MODV) | United States | $0.368B | 6.88 |
| DocGo (DCGO) | United States | $0.314B | 17.17 |
| LifeMD (LFMD) | United States | $0.289B | 0.00 |
| MultiPlan (MPLN) | United States | $0.236B | 0.00 |
| Beauty Health (SKIN) | United States | $0.221B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.217B | 0.00 |
| Biodesix (BDSX) | United States | $0.196B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.189B | 0.00 |
| So-Young (SY) | China | $0.108B | 52.00 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.046B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 5.72 |
| IceCure Medical (ICCM) | Israel | $0.034B | 0.00 |
| Oncology Institute (TOI) | United States | $0.033B | 0.00 |
| Nutex Health (NUTX) | United States | $0.028B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.026B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| KindlyMD (KDLY) | $0.017B | 0.00 | |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| DermTech (DMTK) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.002B | 0.00 |